Clinical evaluation of cefuroxime axetil(CXM-AX) on acne pustulosa.
スポンサーリンク
概要
- 論文の詳細を見る
We performed clinical evaluation of cefuroxime axetil (CXM-AX) in 26 cases with acne pustulosa. Thirteen cases were treated with 1500mg/day CXM-AX and 13 cases with 750 mg/day CXM-AX. Out of 13 cases with 1500mg/day, 5 cases were remarkably improved and 6 cases were improved. The efficacy rate of 1500mg/day group were 84.6%. Out of 13cases with 750mg/day, 3 cases were remarkably improved, 9 cases were improved and one case was drop out because of her business. Except one case who was drop out from this trial, all cases with 750mg/day were improved.<BR>Adverse effects were observed in 2 cases of 1500mg/day group, both of them were gastrointestinal tract symptoms: gastric pain. The adverse events were disappeared shortly after the discontinuance of the drug.<BR>From the results of this clinical trial, we decided that 750mg/day of CXM-AX was enough and safe to treat acne pustulosa effec tively.
- 日本皮膚科学会大阪地方会の論文
日本皮膚科学会大阪地方会 | 論文
- ツベルクリン皮内反応部に出現する浸潤細胞の電顕的観察
- セフメタゾ-ル・ナトリウムによりSystemic eczematous contact-type dermatitis medicamentosaと急性腎不全を生じた1例 (単純化学物質による皮膚障害)
- 歯科金属アレルギ-による全身の扁平苔癬の1例 (接触皮膚炎とパッチテスト-4-)
- Oakmoss Allergyを示すPigmented Cosmetic Dermatitisの1例 (単純化学物質による皮膚障害)
- 漢方薬中のCinnamic系化合物による薬疹の1例 (単純化学物質による皮膚障害) -- (職業性および薬剤性皮膚炎と薬疹)